Company intelligence / Profile preview

Consonance Capital

New York, NY, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Consonance Capital is an active private equity healthcare investment firm with a strong record investing in growth equity, buyouts, and recapitalizations across healthcare services, pharmaceuticals, medical devices, and specialty distribution. Their hedge fund division is inactive, but they continue to manage existing funds. They do not directly conduct clinical trials, but several portfolio companies (e.g., Mersana Therapeutics, Surrozen) have ongoing clinical programs.

Therapeutic areas: ImmunologyRare DiseasesOtherPsychiatryOncology
Modalities: Small moleculeBiologicMonoclonal antibodyAntibody-drug conjugate
Industry: Investors

Partnerships

Works with portfolio companies and occasionally with large healthcare corporates on carve-outs, divestitures (no recurring pharma co-development cited)

Beyond the preview

Go deeper on Consonance Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Consonance Capital.

Explore the full profile